Amifostine
Amifostine is a pharmaceutical drug with 20 clinical trials. Historical success rate of 73.3%.
Success Metrics
Based on 11 completed trials
Phase Distribution
Phase Distribution
5
Early Stage
12
Mid Stage
3
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
64.7%
11 of 17 finished
35.3%
6 ended early
0
trials recruiting
20
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Study of Cytoreductive Surgery and Hyperthermic Intrathoracic Pleural Chemotherapy (HITC) With Escalating Doses for Children and Adolescents With Unilateral Pleural Malignancy
A Study of Amifostine (Ethyol) in Patients With Colorectal Cancer
Radiation Therapy, Amifostine, and Chemotherapy in Treating Young Patients With Newly Diagnosed Nasopharyngeal Cancer
High Dose Chemotherapy With Amifostine and Autologous Stem Cell Transplantation for High Risk Relapsed Pediatric Solid Tumors and Brain Tumors
Prospective Study of Head and Neck Cancer Radiation Treatment With or Without Amifostine
Clinical Trials (20)
Study of Cytoreductive Surgery and Hyperthermic Intrathoracic Pleural Chemotherapy (HITC) With Escalating Doses for Children and Adolescents With Unilateral Pleural Malignancy
A Study of Amifostine (Ethyol) in Patients With Colorectal Cancer
Radiation Therapy, Amifostine, and Chemotherapy in Treating Young Patients With Newly Diagnosed Nasopharyngeal Cancer
High Dose Chemotherapy With Amifostine and Autologous Stem Cell Transplantation for High Risk Relapsed Pediatric Solid Tumors and Brain Tumors
Prospective Study of Head and Neck Cancer Radiation Treatment With or Without Amifostine
Cisplatin and Docetaxel Plus Docetaxel and Radiotherapy With Amifostine for Squamous Cell Carcinoma of the Head and Neck
Radiation-protection Effect of Amifostine in Locally Advanced Rectal Cancer
A Study of Amifostine for Prevention of Facial Numbness in Radiosurgery Treatment of Trigeminal Neuralgia
EVALUATION OF AMIFOSTINE FOR MUCOSAL AND HEMOPOETIC PROTECTION AND CARBOPLATIN, TAXOL, RADIOTHERAPY IN THE MANAGEMENT OF PATIENTS WITH HEAD AND NECK CANCER.(GCC 0202)
Extrapleural Pneumonectomy /Pleurectomy Decortication, IHOC Cisplatin and Gemcitabine With Amifostine and Sodium Thiosulfate Cytoprotection for Resectable Malignant Pleural Mesothelioma
High-dose ICE With Amifostine
Randomized Amifostine For SCCHN
A Phase II Study of Amifostine for the Prevention of Acute Radiation-Induced Rectal Toxicity
Radiation With Chemotherapy and a Study Drug to the Para-Aortic Nodes in Cervical Cancer
Amifostine in Treating Peripheral Neuropathy Caused by Paclitaxel in Patients With Solid Tumors
Combination Chemotherapy With or Without Amifostine in Treating Patients With Recurrent or Refractory Non-Hodgkin's Lymphoma or Hodgkin's Disease Undergoing Stem Cell Transplantation
Amifostine With IMRT for Submandibular and Sublingual Salivary Sparing During Head and Neck Cancer Treatment
Amifostine for Head and Neck Irradiation in Lymphoma
Subcutaneous Amifostine (Ethyol®) in the Prevention of Radiochemotherapy-Induced Esophagitis and Pneumonitis in Patients With Unresectable Non-Small Cell Lung Cancer
Phase I Study of Amifostine in Patients With Bone Marrow Failure Related to Fanconi's Anemia
All 20 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 20